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   抗菌剤の膀胱腔内への移行にかんする研究．．
i．両腎摘除ラットにおける各種抗菌剤の血清ならびに膀胱
               内生理的食塩水中濃度について
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1． SERUM AND INTRAVESICAL SALINE CONCENTRATION
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    ln order to obtain the basic data regarding the prevention and treatment of infection of the defunc－
tionalized bladder， an investigation was made to see if the antibacterial agent administered generally
is transfered into the intravesical space．
   Male rats， weighing 300 to 350 grams， were nephrectomized bilaterally and their penis was ligated．
The bladder was instilled with O．7 ml of normai saline． This was designated as the intravesical fiuid．
Various antibacterial agents were administered to these rats which were sacrificed 24， 48， and 72 hours
after that in order to determine the serum and intravcs玉ca田uid concentration of the agents．
    In aminoglycoside group such as kanamycin， DKB and gentamicin， the serum cQngentratign
showed a relatively high level even at 72 hours following the gradual decline． The intravesical fluid
concentration shoWed the peak level at 48． hours and the almost same level with the serum at 72 hours．
    In rifampicin and nalidixic acid， the serum concentration decreased in the course of time． ， Anti－
bacterial activity was proved in the 72 hours serum in rifampicin and 48 hours serum in nalidixic
acid． lntravesical fluid also showed small activities．
    In aminobenzyl－peniciilin， sulbenicillin and cefamezin， tiny activity was proved in the serum
and in！ravesical fluid． Aminobenzyl－penicillin or sulbenicillin dis’appeareq from the serum and
cefamezin from the intravesical fluid in the early period of the experitnent．
    In vitro stability of aminobepzyl－penicillin， cefamezin， kanamycin and olgandomycin in the
intravesica！ fluid was examined． ． In aminobenzyl－penicillin and cefamezin， contaminated bacteria
achieving growth during the experiment might have enhanced the inactivation．



































 Kanamycin sulfate（KM：力価700 mcg／mg，明治
製菓株式会社）
 3，，4，一dideoxykanarnycin B sulfate（DKB：力価700
mcg／mg，明治製菓株式会社）



















 KM， DKB， GM， ABPC， SBPC， CET， CEZの
測定には，Bacillus subtilis ATCG 6633を検定菌とし
て用い，培地には，つぎの組成のものを使用した．
 ポリペプトン5g，肉エキス3g，クエン酸ナトリウ
ム10g，寒天（栄研）10g，蒸溜水1，000 ml， pH 7．2
 RFPの濃度測定には， Bacillus subtilis ATCC 6633
を検定菌とし，普通寒天培地（栄研pH 7．0）を用い
た．






























 KM， DKB， GMはO．！Mリン酸緩衝液（pH．78）
で溶解し，KM， DK：Bは40 mg／kg of body weightを，
GMは10mg／kg of body weightを大腿筋肉内に投
与した．
 SBPC， ABPC， CEZ， CET， OLMはO．15Mリン
酸緩衝液（pH 7．0）で溶解し，40 mg／kg of body weight
を大腿筋肉内に投与した．
 RFPは0．5％carboxymethylcerlose－Na水溶液で


























用いた．Bacitlus subtilis ATCC 6633を検定菌として
使用した場合には，胞子浮遊液1．0×108 spores／mlを
1．5％1（なるように培地に植菌し，シャーレ（テルモ社



























 試験に供した抗菌剤は，KM， DKB， GM， CEZ，












膀胱内幽幽との等量混合液をMilipore filter HA O45
でろ過滅菌した溶液を用意した．
 3．試験管内安定性の検討




































Table 1． Cgncentrations of various antirr｝icrobial drugs in serum and in the
     saline＊ 24， t18 and 72 hours after administration to anephric rats．
     ＊ O．7 ml of normal saline which was instilled into the bladders of
     anephric rats and recovered from them．
24－hr・一一leve1 48－hr．一fievei 72－hf一一level
Serum 丁he sallne Serum The saline Serum Thesaline
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O’一一C） The saline，at 570C
 O 24 48 72           hrs








O一一〇 The soline． ot 57eC
       ’
   O 24 48 72            hrs






O一”’一〇 The saline， at 570C
   O 24 48 72              hrs








O－K） The soline，at 570C
 24 48 72          hrs














◎紳一一◎  丁he saline，ot 37℃
      O 24 48 72                  hrs















O一’一〇 The soline，at 570C
  O 24 48 72             hr＄








◎一一一Q  The saline， ot 370C
 24 48 72        hrs







O’－aO The saiine，at 37eC
 O 24 48 72             hrs
Fig． 7． ln vitro stability of CEFI’．
 50 mcg／ml抗生剤リン酸緩衝液と膀胱内腔液との等
































  O 24 48 72              hrs
































  O 24 48 72          hrs
Fig． 10． ln vitro stability of CEZ．
KM， ABPC， CEZおよびOLMの抗菌活性の推移
を調べた．






















  O 24 48 72             hrs
Fig． 12． ln evitro stability of OLM．









 24 48 72          hrs






i ： The soiine
  O 24 48 72             hrs













  Barbitrote buffer． et 570pu        ’“ 135．5 e 146．o
5．0 6．0 7．0 8．0 9，0           pH
Fig． 14． Effect of pH on activity of KM．
    5，0 6．0 7，0 8．0 9．O                 pH
Fig． 16． Effect of plil on activity of CEZ．






    5．0 60 7．0 8．0 9．O           pH


















    5．0 6．0 ZO 8．0 9．O           pH
Fig． 17． Effect of pH on activity of OLM．






formaldehyde22）， para－aminohippuric acidi5）， pen－
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